CD274 and neoplasm: These studies demonstrate that the WEE1 inhibitor-ATRi combination induces an immune response not only by regulating the cell cycle and HR but also by activating the STING signaling pathway, enhancing the type I interferon (IFN-IS) response, acting on tumor-infiltrating lymphocytes, and upregulating PD-L1 expression.